FLEXIOSS

TRICUREAN

Calcium Phosphate (Synthetic Hydroxyapatite)

Curdlan (Sugar Polymer)

Glucan (β-1,3)

FlexiOss Bone Regenerative Biomaterial - Third Generation Tricurean

FlexiOss® Ortho

CMDR-2025-04943A

FlexiOss® Dent

CMDR-2025-04943B

THIRD GENERATION REGENERATIVE TRICUREAN BONE FILLER

Next-generation implantable biomaterial engineered for advanced bone defect filling and regenerative medicine. FlexiOss® represents a breakthrough in regenerative medicine with its unique biphasic composition and bioactive properties.

PRODUCT LINE

FLEXIOSS® FAMILY

Third Generation Regenerative Tricurean Bone Filler - Available in specialized formulations

FlexiOss® Ortho

PH-FDA: Orthopedic Applications
FlexiOss® Ortho

Third generation biomaterial for orthopedic applications. Biphasic composition with mechanical parameters similar to cancellous bone. Suitable for defects up to 7 cm in length.

KEY APPLICATIONS

  • Comminuted fractures with bone tissue defects
  • Long bone defect filling and reconstruction
  • Trauma surgery and emergency medicine
  • Bone pocket filling for tissue regeneration
More Information

FlexiOss® Dent

PH-FDA: Dental & Maxillofacial
FlexiOss® Dent

Modern implantable biomaterial specifically designed for dental and maxillofacial procedures. Flexible, bioactive, and supports bone tissue regeneration. Available in 1cm, 3cm, and 5cm sizes.

KEY APPLICATIONS

  • Post-extraction alveolar bone augmentation
  • Dental implant site preparation
  • Maxillofacial reconstructive procedures
  • Treatment of gingival resection with bone atrophy
  • Filling defects after cystotomy and root resection
More Information

FlexiOss® Vet

PH-FDA: Veterinary Applications
FlexiOss® Vet

3rd generation veterinary biomaterial. Absorbs blood and drug solutions, serves as antibiotic carrier. Bone healing time reduced by half. Proven in dogs, cats, and companion animals.

KEY APPLICATIONS

  • Teeth extraction and bone filling
  • Oronasal fistulae treatment
  • Angular deformity correction (tibial osteotomy)
  • Periodontal disease and EOTRH syndrome
More Information

All FlexiOss® products feature the same proven biphasic composition: 60% Hydroxyapatite Matrix, 35% β-1,3-Glucan Polymer, and 5% Bioactive Additives.

Exclusively distributed in the Philippines by Fortschritt Medical Supplies Inc.

WHAT MAKES FLEXIOSS® UNIQUE

INNOVATIVE PROPERTIES

The main features that distinguish FlexiOss® from other bone substitute materials on the market

Surgical Handiness

Flexible after soaking (plastic and bendable) - allows fitting during operation to individual bone defects by cutting or bending

Can Be Milled

In dry state, FlexiOss® can be milled enabling personalization of the composite implant for each patient

Faster Ossification

High specific surface area and ionic reactivity increases mineralization rate within implantation site and accelerates new bone tissue formation

Minimizes Contamination Risk

Application of carbohydrate polymer minimizes risk of viruses and prions contamination. Curdlan forms collagen-like triple helix

High Soaking Capacity

Can be soaked in antibacterial drugs minimizing perioperative infections, or in PRP and growth factors resembling expensive BMP-2-type bone substitutes

Easy Storage & Transport

Non-animal material (lowering risk of pathogen transmission and allergic reactions). Simple storage and transportation requirements

Clinical Advantages

Medical Benefits

Reduced Healing Time

Bone healing time reduced by half compared to standard treatment

Antibiotic Carrier

Can be soaked in antibacterial drugs, minimizing perioperative infections

Growth Factor Compatibility

Compatible with PRP and growth factors for enhanced regeneration

Surgical Advantages

Customizable During Surgery

Can be cut, bent, or milled to fit individual defects perfectly

Haemostatic Properties

Reduces bleeding from operation site

No Reoperation Needed

Biomaterial remodels naturally - eliminates removal surgery

DISCOVER FLEXIOSS®

THE REVOLUTION IN BONE REGENERATION

Watch how FlexiOss® is transforming bone regenerative medicine worldwide

0%

Faster Healing

0%

Biocompatible

0rd Gen

Biomaterial Tech

Experience the Future of Regenerative Medicine

FlexiOss® combines cutting-edge biomaterial science with proven clinical results. Our third-generation Tricurean bone filler delivers superior outcomes in orthopedic, dental, and veterinary applications.

Flexible & Moldable

Customizable during surgery to fit any bone defect

Bioactive Properties

Actively supports natural bone regeneration

Drug Delivery System

Can be soaked in antibiotics or growth factors

Proven Results

Extensive clinical studies and successful outcomes

AWARDS & RECOGNITION

MEDICAL INVENTI

Top Biomaterials Processing Company

Europe 2024 • Life Sciences Review

Medical Inventi Award

"FLEXIOSS WAS SUPPOSED TO LAUNCH QUIETLY... LOOKS LIKE INNOVATION NEVER STAYS SILENT!"

INTERACTIVE 3D SHOWCASE

EXPLORE FLEXIOSS® IN 3D

Interact with our revolutionary biomaterial. Rotate, zoom, and explore every detail.

Drag • Zoom
Interactive 3D

Product Specifications

Composition

Biphasic HAp-Polymer

Porosity

65-75%

Pore Size

100-500μm

Resorption

6-24 Months

Flexible & Moldable: Can be cut, bent, or milled to fit individual defects

Bioactive: Actively supports bone tissue regeneration

Drug Carrier: Can be soaked in antibiotics or growth factors

DISCOVER THE FUTURE OF BONE REGENERATION

Experience FlexiOss® - the revolutionary biomaterial trusted by medical professionals worldwide. Third generation technology designed for superior clinical outcomes.

SCIENTIFIC RESEARCH

PUBLISHED RESEARCH

Peer-reviewed scientific publications validating FlexiOss® efficacy and safety

Characteristics and application of FlexiOss® bone substitute material in trauma-orthopedic patients

Lukasiewicz P.

Medical Inventi2025

Preliminary Results of Surgical Treatment for Enchondroma Using a Novel Bioactive and Osseoconductive HAP/β-Glucan Bone Substitute FlexiOss® — Case Series

Kotrych D., Ciechanowicz D., Bielewicz F., Baryluk A., Podsiadlo S., Zietek P.

J. Clin. Med. 2025, 14(11), 37382025

Behavior of new hydroxyapatite/glucan composite in human serum

Borkowski L., Lubek T., Jojczuk M., Nogalski A., Belcarz A., Palka K., Hajnos M., Ginalska G.

J. Biomed. Mater. Res. Part B., 2018, 106B(7), 2653-26642018

The comparison study of bioactivity between composites containing synthetic non-substituted and carbonate-substituted hydroxyapatite

Borkowski L., Sroka-Bartnicka A., et al.

Mater. Sci. Eng. C Mater. Biol. Appl. 2016, 62, 260-2672016

Biphasic mode of antibacterial action of aminoglycoside antibiotics-loaded elastic hydroxyapatite-glucan composite

Belcarz A., Zima A., Ginalska G.

Int. J. Pharm. 2013, 454, 285-2952013

Application of β-1,3-glucan in production of ceramics-based elastic composite for bone repair

Belcarz A., Ginalska G., Pycka T., et al.

Centr. Eur. J. Biol. 2013, 8, 534-5482013
FlexiOss Background

FLEXIOSS

AVAILABLE NOW
2025
YEAR

Exclusively distributed by Fortschritt Medical Supplies Inc.